Description
Pivikto 150mg Tablet is a medication containing the active ingredient Rivaroxaban. Rivaroxaban is a direct oral anticoagulant that works by inhibiting Factor Xa, a crucial component in the blood clotting cascade. By blocking Factor Xa, Pivikto effectively reduces thrombin generation, thereby preventing the formation of blood clots. This makes it valuable in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent DVT and PE in patients who have undergone hip or knee replacement surgery. The typical dosage is 150mg once daily, but this can vary based on the patient’s condition and medical history. Common side effects may include bleeding, bruising, and gastrointestinal upset. It is essential to take Pivikto exactly as prescribed by your healthcare provider. Store the tablets at room temperature, away from moisture and heat.
